To answer this question, Gia stated: “The APOL1 risk variants evolved about four thousand years ago in Sub-Saharan Africa to protect against sleeping sickness.” That statement was well received by focus group members because it recast APOL1 risk variants in a positive light by highlighting a strength of people of African ancestry. The gene discussed is APOL1; the disease is human African trypanosomiasis.